Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Royal Society 2021 Africa Prize lecture from Professor George Warimwe. More than 70% of emerging infectious diseases (including viruses) are zoonotic, meaning they are acquired from animals, with some causing serious illness and death in humans as well as the animal host. But, what if we could immunise both humans and animals with the same vaccine?

The development and deployment of vaccines against emerging infectious diseases is a priority for global health security. More than 70% of these infectious diseases are zoonotic, meaning they are acquired from animals, with some causing serious illness and death in humans as well as the respective animal host. Despite this, the study of host-pathogen interactions that underlie disease pathogenesis and the mechanisms through which immunity is acquired are often done in medical and veterinary ‘silos’, with little interaction between the two. A ‘one health’ approach that integrates the scientific insights from veterinary and human studies may accelerate progress in the design and development of countermeasures against zoonotic diseases.

Rift Valley Fever, a zoonotic disease that causes epidemics in Africa, is among a shortlist of diseases prioritised by the World Health Organization for urgent development of vaccines. In this talk, Professor George Warimwe will discuss his ‘one health vaccinology’ approach to developing a single Rift Valley Fever vaccine suitable for human and livestock use.

Professor Warimwe's talk is followed by a Q&A chaired by Sir Jeremy James Farrar OBE FRS FMedSci.

Similar stories

Abhilasha Karkey, new OUCRU Nepal Director

OUCRU Nepal is pleased to announce that as of 01 October 2022, Dr Abhilasha Karkey will assume the role of Director.

Oxford University named world’s top university for the 7th consecutive year

The University of Oxford has been named the best university in the world for a record seventh consecutive year in the Times Higher Education (THE) World University Rankings 2023.

Four CTMGH researchers awarded full professorships

We are delighted to announce that four of our researchers have been awarded the title of Professor, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine, University of Oxford.

Quality of care, health workers’ well-being and COVID-19

Nurses are central players in the provision of quality health care globally. Although neonatal units have not been at the epicenter of the current COVID-19 pandemic, challenges have also been raised for neonatal nurses. KWTRP share their COVID-19 related experiences and challenges, highlight strategies they used to manage the challenges and show how elements of the communication skills and emotional competence course helped them cope.

High prevalence of antibodies against COVID-19 within the general population: Evidence from Nairobi and Kilifi

By May 2022, 69% of individuals residing within the Kilifi Health and Demographic System (HDSS) and 91% residing within the Nairobi Urban HDSS had evidence of an immune response to COVID-19 resulting from natural infection and/or vaccination, i.e., anti-spike IgG antibodies.

Dengue Research Article Awarded The 2021 – 2022 Alexandre Yersin Prize for Outstanding Publications

OUCRU research article titled ‘Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes’ was recently awarded the 2021-2022 Alexandre Yersin Prize for Outstanding Publications.